BiVictriX Therapeutics PLC (AIM:BVX, OTC:BVTXF), an emerging biotechnology company applying a novel approach to develop next-generation cancer therapies.
Investegate |BiVictriX Therapcts. Announcements | BiVictriX Therapcts.: Director Dealing investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
TRADING UPDATES: Byotrol anticipating positive full-year earnings lse.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lse.co.uk Daily Mail and Mail on Sunday newspapers.
BiVictriX Therapeutics PLC (AIM:BVX, OTC:BVTXF) has confirmed it will be ready to nominate a lead candidate from its BVX001 drug programme in the fourth.